Delavirdine

This classification denotes a reverse transcriptase inhibitor with the molecular formula C22H28N6O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DOL5F9JD3E, chemically known as piperazine, 1-(3-((1-methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1h-indol-2-yl)carbonyl)- but generally known as delavirdine, which bears US NIH Compound Identifier 5625. European Medicines Agency schedules Delavirdine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06949MIG. The term DELAVIRDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules delavirdine in its Anatomical Therapeutic Chemical (ATC) Classification. DELAVIRDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule delavirdine under HS 29350090 and SITC 51580. As of Q4 2014, DELAVIRDINE remains the US FDA Preferred Term for this commodity. Delavirdine bears US NLM identifiers UMLS ID C0288165 and NCI Concept Code C65366. SMILES: S(=O)(=O)(NC1CC2CC([NH]C2CC1)C(=O)N1CCN(CC1)C1NCCCC1NC(C)C)C.